|
1
|
Meltzer MS, Nakamura M, Hansen BD, Turpin
JA, Kalter DC and Gendelman HE: Macrophages as susceptible targets
for HIV infection, persistent viral reservoirs in tissue and key
immunoregulatory cells that control levels of virus replication and
extent of disease. AIDS Res Hum Retroviruses. 6:967–971.
1990.PubMed/NCBI
|
|
2
|
Balestra E, Perno CF, Aquaro S, Panti S,
Bertoli A, Piacentini M, Forbici F, D'Arrigo R, Calió R and Garaci
E: Macrophages: A crucial reservoir for human immunodeficiency
virus in the body. J Biol Regul Homeost Agents. 15:272–276.
2001.PubMed/NCBI
|
|
3
|
Kedzierska K and Crowe SM: The role of
monocytes and macrophages in the pathogenesis of HIV-1 infection.
Curr Med Chem. 9:1893–1903. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fantuzzi L, Belardelli F and Gessani S:
Monocyte/macrophage-derived CC chemokines and their modulation by
HIV-1 and cytokines: A complex network of interactions influencing
viral replication and AIDS pathogenesis. J Leukoc Biol. 74:719–725.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leonis MA, Thobe MN and Waltz SE:
Ron-receptor tyrosine kinase in tumorigenesis and metastasis.
Future Oncol. 3:441–448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Correll PH, Morrison AC and Lutz MA:
Receptor tyrosine kinases and the regulation of macrophage
activation. J Leukoc Biol. 75:731–737. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang MH, Julian FM, Breathnach R, Godowski
PJ, Takehara T, Yoshikawa W, Hagiya M and Leonard EJ: Macrophage
stimulating protein (MSP) binds to its receptor via the MSP beta
chain. J Biol Chem. 272:16999–17004. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang MH, Cox GW, Yoshimura T, Sheffler LA,
Skeel A and Leonard EJ: Macrophage-stimulating protein inhibits
induction of nitric oxide production by endotoxin- or
cytokine-stimulated mouse macrophages. J Biol Chem.
269:14027–14031. 1994.PubMed/NCBI
|
|
9
|
Chen YQ, Fisher JH and Wang MH: Activation
of the RON receptor tyrosine kinase inhibits inducible nitric oxide
synthase (iNOS) expression by murine peritoneal exudate
macrophages: Phosphatidylinositol-3 kinase is required for
RON-mediated inhibition of iNOS expression. J Immunol.
161:4950–4959. 1998.PubMed/NCBI
|
|
10
|
Liu QP, Fruit K, Ward J and Correll PH:
Negative regulation of macrophage activation in response to
IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine
kinase. J Immunol. 163:6606–6613. 1999.PubMed/NCBI
|
|
11
|
Morrison AC, Wilson CB, Ray M and Correll
PH: Macrophage-stimulating protein, the ligand for the stem
cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits
IL-12 production by primary peritoneal macrophages stimulated with
IFN-gamma and lipopolysaccharide. J Immunol. 172:1825–1832. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morrison AC and Correll PH: Activation of
the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase
by macrophage-stimulating protein results in the induction of
arginase activity in murine peritoneal macrophages. J Immunol.
168:853–860. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Correll PH, Iwama A, Tondat S, Mayrhofer
G, Suda T and Bernstein A: Deregulated inflammatory response in
mice lacking the STK/RON receptor tyrosine kinase. Genes Funct.
1:69–83. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leonis MA, Toney-Earley K, Degen SJ and
Waltz SE: Deletion of the Ron receptor tyrosine kinase domain in
mice provides protection from endotoxin-induced acute liver
failure. Hepatology. 36:1053–1060. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsutsui S, Noorbakhsh F, Sullivan A,
Henderson AJ, Warren K, Toney-Earley K, Waltz SE and Power C:
RON-regulated innate immunity is protective in an animal model of
multiple sclerosis. Ann Neurol. 57:883–895. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Klatt A, Zhang Z, Kalantari P, Hankey PA,
Gilmour DS and Henderson AJ: The receptor tyrosine kinase RON
represses HIV-1 transcription by targeting RNA polymerase II
processivity. J Immunol. 180:1670–1677. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee ES, Kalantari P, Tsutsui Section S,
Klatt A, Holden J, Correll PH, Power Section C and Henderson AJ:
RON receptor tyrosine kinase, a negative regulator of inflammation,
inhibits HIV-1 transcription in monocytes/macrophages and is
decreased in brain tissue from patients with AIDS. J Immunol.
173:6864–6872. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Griffin GE, Leung K, Folks TM, Kunkel S
and Nabel GJ: Activation of HIV gene expression during monocyte
differentiation by induction of NF-kappa B. Nature. 339:70–73.
1989. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Harrich D, Garcia J, Wu F, Mitsuyasu R,
Gonazalez J and Gaynor R: Role of SP1-binding domains in in vivo
transcriptional regulation of the human immunodeficiency virus type
1 long terminal repeat. J Virol. 63:2585–2591. 1989.PubMed/NCBI
|
|
20
|
Henderson AJ, Connor RI and Calame KL:
C/EBP activators are required for HIV-1 replication and proviral
induction in monocytic cell lines. Immunity. 5:91–101. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Agbottah E, Deng L, Dannenberg LO, Pumfery
A and Kashanchi F: Effect of SWI/SNF chromatin remodeling complex
on HIV-1 Tat activated transcription. Retrovirology. 3:482006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mahmoudi T, Parra M, Vries RG, Kauder SE,
Verrijzer CP, Ott M and Verdin E: The SWI/SNF chromatin-remodeling
complex is a cofactor for Tat transactivation of the HIV promoter.
J Biol Chem. 281:19960–19968. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tréand C, du Chéné I, Brès V, Kiernan R,
Benarous R, Benkirane M and Emiliani S: Requirement for SWI/SNF
chromatin-remodeling complex in Tat-mediated activation of the
HIV-1 promoter. Embo J. 25:1690–1699. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kalantari P, Harandi OF, Hankey PA and
Henderson AJ: HIV-1 Tat mediates degradation of RON receptor
tyrosine kinase, a regulator of inflammation. J Immunol.
181:1548–1555. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Feng T, Shao X, Li J, et al: Human
immunodeficiency virus (HIV)-1 Tat downregulates the
phosphorylation of recepteur d'origine nantais (RON) receptor
tyrosine kinase induced by macrophage-stimulating protein. African
Journal of Biotechnology. 10:16610–16616. 2013.
|
|
26
|
Schneider E, Whitmore S, Glynn KM,
Dominguez K, Mitsch A and McKenna MT; Centers for Disease Control
and Prevention (CDC): Revised surveillance case definitions for HIV
infection among adults, adolescents, and children aged <18
months and for HIV infection and AIDS among children aged 18 months
to <13 years - United States, 2008. MMWR Recomm Rep. 57:1–12.
2008.PubMed/NCBI
|
|
27
|
Hargreaves N and Scano F: Guidelines for
implementing collaborative TB and HIV programme activities.
2003
|
|
28
|
Lu Y, Yao HP and Wang MH: Multiple
variants of the RON receptor tyrosine kinase: Biochemical
properties, tumorigenic activities and potential drug targets.
Cancer Lett. 257:157–164. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu Y, Yao HP and Wang MH: Significance of
the entire C-terminus in biological activities mediated by the RON
receptor tyrosine kinase and its oncogenic variant RON160. J Exp
Clin Cancer Res. 27:552008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yao HP, Luo YL, Feng L, Cheng LF, Lu Y, Li
W and Wang MH: Agonistic monoclonal antibodies potentiate
tumorigenic and invasive activities of splicing variant of the RON
receptor tyrosine kinase. Cancer Biol Ther. 5:1179–1186. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guin S, Yao HP and Wang MH: RON receptor
tyrosine kinase as a target for delivery of chemodrugs by antibody
directed pathway for cancer cell cytotoxicity. Mol Pharm.
7:386–397. 2010. View Article : Google Scholar
|
|
32
|
Ochsenbauer-Jambor C, Jones J, Heil M,
Zammit KP and Kutsch O: T-cell line for HIV drug screening using
EGFP as a quantitative marker of HIV-1 replication. Biotechniques.
40:91–100. 2006. View Article : Google Scholar : PubMed/NCBI
|
